Clinical Trial Update: Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC). [Phase 4]

View source ↗

Summary

Phase 4 trial of regorafenib in Indian patients with metastatic colorectal cancer has completed. No results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Metastatic Colorectal Cancer | Phase 4 | Status: COMPLETED